Key facts
- It has raised $502.0M across 2 recorded rounds; the latest was PIPE ($502.0M) in Feb 2021.
- 1 institutional filer reports fund marks on Nuvation Bio across 5 filings.
- Nuvation Bio has filed 1 Form D with the SEC, most recently Oct 2020 ($275.3M sold to 57 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Nuvation Bio
Create free account
No card required
Funding rounds
2 roundsFeb 2021PIPE$502.0M▮
About Nuvation Bio
- Industry
- Drug Discovery
PA Mark — not yet priced
Nuvation Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Nuvation Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
1 filers · latest May 20261 SEC-registered fund reported 5 fair-value marks on Nuvation Bio between May 2025 and May 2026. Filer-level marks and implied $/share are available to Pro members.